Elevated Preoperative CEA is Associated with Worse Survival in Stage I-III Rectal Cancer Patients

Overview

Journal Br J Cancer

Specialty Oncology

Date 2012 Jun 28

PMID 22735902

Citations 35

Authors

I Tarantino

R Warschkow

M Worni

K Merati-Kashani

D Koberle

B M Schmied

S A Muller

T Steffen

T Cerny

U Guller

Affiliations

Soon will be listed here.

Abstract

Background: The objective of this investigation was to assess whether preoperative carcinoembryonic antigen (CEA) level is an independent predictor of overall survival in rectal cancer patients.

Methods: All patients (n=504) undergoing a resection for stage I-III rectal cancer at the Kantonsspital St Gallen were included into a database between 1991 and 2008. The impact of preoperative CEA level on overall survival was assessed using risk-adjusted Cox proportional hazard regression models and propensity score methods.

Results: In risk-adjusted Cox proportional hazard regression analyses, preoperative CEA level (hazard ratio (HR): 1.98, 95% confidence interval (CI): 1.36-2.90, P<0.001), distance from anal verge (<5 cm: HR: 1.93, 95% CI: 1.11-3.37; P=0.039), older age (HR: 1.07, 95% CI: 1.05-1.09; P<0.001), lower body mass index (HR: 0.94, 95% CI: 0.89-0.98; P=0.006), advanced tumour stage (stage II HR: 1.41, 95% CI: 0.85-2.32; stage III HR: 2.08, 95% CI: 1.31-3.31; P=0.004), R 1 resection (HR: 5.65, 95% CI: 1.59-20.1; P=0.005) and chronic kidney disease (HR: 2.28, 95% CI: 1.03-5.04; P=0.049) were all predictors for poor overall survival.

Conclusion: This is one of the first investigations based on a large cohort of exclusively rectal cancer patients demonstrating that preoperative CEA level is a strong predictor of decreased overall survival. Preoperative CEA should be used as a prognostic factor in the preoperative assessment of rectal cancer patients.

Citing Articles

Preoperative Carcinoembryonic Antigen as a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff.

Keshvari A, Ahmadi Tafti S, Keramati M, Fazeli M, Kazemeini A, Behboudi B J Gastrointest Cancer. 2025; 56(1):46.

PMID: 39826023 DOI: 10.1007/s12029-025-01175-2.

Current Surgical Methods in Local Rectal Excision.

Semanjski K, Luzaic K, Brkic J Gastrointest Tumors. 2024; 10(1):44-56.

PMID: 39015761 PMC: 11249472. DOI: 10.1159/000538958.

Serum tumor marker and CT body composition scoring system predicts outcomes in colorectal cancer surgical patients.

Song M, Liu Z, Wu F, Nie T, Heng Y, Xu J Eur Radiol. 2024; 34(12):7596-7608.

PMID: 38913246 PMC: 11557714. DOI: 10.1007/s00330-024-10849-7.

Complications Rate and Related Factors After Laparoscopic Sphincter-Preserving Total Mesorectal Excision for Low Rectal Cancer: A Single-Center Study in Vietnam.

Phu L, Bang H, Van Viet U, Tan H, Tin N Cureus. 2024; 16(5):e60734.

PMID: 38774464 PMC: 11107394. DOI: 10.7759/cureus.60734.

Extracellular water to total body water ratio, a novel predictor of recurrence in patients with colorectal cancer.

Horino T, Tokunaga R, Miyamoto Y, Akiyama T, Daitoku N, Sakamoto Y Ann Gastroenterol Surg. 2024; 8(1):98-106.

PMID: 38250685 PMC: 10797841. DOI: 10.1002/ags3.12728.

References

Knight C, Griffen F . An improved technique for low anterior resection of the rectum using the EEA stapler. Surgery. 1980; 88(5):710-4. View

Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S . Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol. 2010; 17(9):2349-56. DOI: 10.1245/s10434-010-1004-5. View

Diez M, Pollan M, Muguerza J, Gaspar M, Duce A, Alvarez M . Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer. 2000; 88(1):35-41. DOI: 10.1002/(sici)1097-0142(20000101)88:1<35::aid-cncr6>3.3.co;2-g. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Lin J, Lin C, Yang S, Wang H, Jiang J, Lan Y . Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis. 2011; 26(9):1135-41. DOI: 10.1007/s00384-011-1209-5. View

Chapman M, Buckley D, Henson D, Armitage N . Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer. 1998; 78(10):1346-9. PMC: 2063189. DOI: 10.1038/bjc.1998.682. View

Perez R, Sao Juliao G, Habr-Gama A, Kiss D, Proscurshim I, Campos F . The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum. 2009; 52(6):1137-43. DOI: 10.1007/DCR.0b013e31819ef76b. View

Sun L, Chu K, Cheng S, Lu C, Kuo C, Hsieh J . Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer. 2009; 9:288. PMC: 2745428. DOI: 10.1186/1471-2407-9-288. View

Govindarajulu U, Lin H, Lunetta K, DAgostino Sr R . Frailty models: Applications to biomedical and genetic studies. Stat Med. 2011; 30(22):2754-64. DOI: 10.1002/sim.4277. View

10.

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R . Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; 351(17):1731-40. DOI: 10.1056/NEJMoa040694. View

11.

Kim J, Kim N, Sohn S, Kim Y, Kim K, Hur H . Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol. 2009; 16(10):2771-8. PMC: 2749169. DOI: 10.1245/s10434-009-0651-x. View

12.

Locker G, Hamilton S, Harris J, Jessup J, Kemeny N, Macdonald J . ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24(33):5313-27. DOI: 10.1200/JCO.2006.08.2644. View

13.

Rubin D . Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1998; 127(8 Pt 2):757-63. DOI: 10.7326/0003-4819-127-8_part_2-199710151-00064. View

14.

Li M, Li J, Zhao A, He J, Zhou L, Li Y . Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer. Colorectal Dis. 2008; 11(3):276-81. PMC: 3002045. DOI: 10.1111/j.1463-1318.2008.01591.x. View

15.

Boonpipattanapong T, Chewatanakornkul S . Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006; 40(7):592-5. DOI: 10.1097/00004836-200608000-00006. View

16.

Fueglistaler P, Adamina M, Guller U . Non-inferiority trials in surgical oncology. Ann Surg Oncol. 2007; 14(5):1532-9. DOI: 10.1245/s10434-006-9295-2. View

17.

Zaheer S, Pemberton J, Farouk R, Dozois R, Wolff B, Ilstrup D . Surgical treatment of adenocarcinoma of the rectum. Ann Surg. 1998; 227(6):800-11. PMC: 1191380. DOI: 10.1097/00000658-199806000-00003. View

18.

Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S . Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol. 2008; 15(12):3433-9. DOI: 10.1245/s10434-008-0168-8. View

19.

Grossmann I, de Bock G, Kranenbarg W, van de Velde C, Wiggers T . Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol. 2006; 33(2):183-7. DOI: 10.1016/j.ejso.2006.10.035. View

20.

Park I, Choi G, Lim K, Kang B, Jun S . Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol. 2009; 16(11):3087-93. DOI: 10.1245/s10434-009-0625-z. View